Westlake Corporation (WLK) Reports $58M Adjusted Net Income; EBITDA Falls 40% Sequentially

Westlake Corporation (WLK) reported Q3 2026 net sales of $3.0B and net income of $6M, or $0.05 per share. Adjusted net income was $58M, or $0.45 per share, while adjusted EBITDA fell 40% sequentially to $408M. The company cited softer pricing and European cost pressures.

Original reporting
Published Nov 4, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westlake Corporation (WLK) Reports $58M Adjusted Net Income; EBITDA Falls 40% Sequentially — source image
Decision brief

The 30-second read

$WLKBearishMed
01

Why it matters

The earnings numbers introduce new information on profitability trends, prompting a reassessment of valuation.

02

Market read

The earnings release provides fresh data that could move Westlake's stock and influence sector sentiment.

03

What to watch

Potential cost‑saving initiatives from capacity optimization may improve margins in the next quarter.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Westlake Corporation released its Q3 2026 earnings, highlighting mixed results with year‑over‑year improvement but a sharp sequential decline.

Company-level read

Ticker impact

$WLKBearishHigh confidence
Context

Westlake reported Q3 2026 adjusted net income of $58M and a 40% sequential drop in adjusted EBITDA to $408M.

Expected impact

likely pressure as investors price in the steep EBITDA decline

Evidence & confidence

The 40% drop in EBITDA signals weaker near‑term profitability, which typically drags the stock lower.

Market effects

The chemicals sector may see broader scrutiny as Westlake's pricing pressure hints at demand softness.

European operations face cost pressure, potentially affecting other U.S. chemicals with EU exposure.

Limited to chemicals and specialty materials investors; no broad market ripple.

Counterpoint

If the EBITDA dip is temporary and pricing recovers, the stock could rebound on a bounce‑back narrative.

Key entities

  • Westlake Corporation

    U.S. chemicals manufacturer (ticker WLK).

Related articles

$WLKMedAI 8/10

Westlake Corp (WLK) (Q3 2026) Earnings Call Highlights: $408 Million EBITDA, Margin

Westlake Corp (WLK) reported Q3 2026 EBITDA of $408M, with HIP segment EBITDA down $20M YoY due to cost inflation and lower sales. PEM profitability was impacted by higher European energy costs and lower polyethylene prices. Management expects cost headwinds to persist into Q4, with limited pricing recognition. Polyethylene demand remains strong, and the company expects European PVC profitability to recover in 2027.

$WLKMed

Westlake Chemical Partners LP Q3 2026 Earnings Call Summary

Westlake Chemical Partners LP reported Q3 2026 net income growth due to higher production and sales volumes. Distributable cash flow rose to $18 million, with a trailing 12-month coverage ratio of 1.09x. Management expects modest benefits from rising ethylene prices in Q4 2026 and plans to begin renegotiating the Ethylene Sales Agreement next year. The company maintains a conservative leverage ratio of 1x and has sustained distributions for 49 consecutive quarters.

$WLKHighAI 8/10

Westlake (WLK) Q3 2026 Earnings Call Transcript

Westlake (WLK) reported Q3 2026 earnings with $3B sales, $408M EBITDA, and $220M free cash flow. Year-over-year growth was driven by margin improvements in the PEM segment and higher sales prices, offset by a decline in HIP EBITDA due to housing market slowdowns. The company's 3-pillar profitability plan contributed $500M EBITDA uplift in 2026, with a full-year target of $600M.

$WLKMedAI 8/10

Westlake Q3 2026 slides: profitability plan delivers amid headwinds

Westlake Corporation (WLK) reported Q3 2026 net sales of $3.0B, EBITDA of $408M, and free cash flow of $220M. Revenue beat estimates, but EPS missed. Shares rose 0.76% post-earnings. Year-over-year growth was strong, but sequential declines were noted due to commodity price volatility and European market challenges. The company maintained a strong balance sheet with $2.0B in cash and investments.